Syngene International Limited Financial Ratios
SYNGENE · Healthcare · Current price ₹387.25
P/E ratio
32.7x
P/B ratio
3.2x
ROE
0.0%
ROCE
8.7%
Debt / Equity
0.09
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 32.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 8.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.09 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Syngene International Limited's latest numbers.
Syngene International Limited profitability
Syngene International Limited generates a return on equity of 0.0% and a return on capital employed of 8.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.09 and a P/E of 32.7x, Syngene International Limited is conservatively financed. Our overall business-quality score for the company is 3.4 / 10.
Understand the ratios
More on Syngene International Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.